Background and Purpose-Accumulated evidence suggests that hemin-a breakdown product of hemoglobin-plays a pivotal role in the inflammatory injuries that result after hemorrhagic stroke through the Toll Like Receptor 2-Toll Like Receptor 4 signal pathway. However, the mechanism of how hemin triggers neuronal necroptosis directly after intracranial hemorrhage (ICH) is still an area of active research. As animal model and preclinical studies have shown, the recombinant interleukin-1 receptor antagonist (IL-1RA) improves clinical outcomes after stroke. As such, we have chosen to investigate the mechanism of how IL-1RA exerts protective effect in hemin-induced neuronal necroptosis after ICH. Methods-Our ICH model was induced by hemin injection in C57BL/6 mice and IL-1R1 −/− mice. In addition, we used primary cultured neurons to assess hemin-induced cell death. Co-immunoprecipitation, immunoblot, immunofluorescent staining, neurological deficit scores, and brain water content were used to study the mechanisms of IL-1R1 modulation in neuronal necroptosis both in vitro and in vivo. Results-Free hemin could mediate neuronal necroptosis directly by assembling necrosome complex and then to trigger cell death. This phenomenon was driven by IL-1R1 as IL-1R1 can form a complex with necrosome. After treatment with IL-1RA, both the expression and translocation of the necrosome decreased while disruption of the interaction between IL-1R1 and RIP1/RIP3 (receptor interacting protein 1/3) increased neuron survival. In addition, the IL-1R1-deficient mice demonstrated lower levels of necrosome components, including RIP1, RIP3, and MLKL (mixed lineage kinase domain-like protein), compared with control groups after hemin treatment. In addition, the neurological deficit scores, brain water content, and inflammatory response were all also reduced in the IL-1R1-deficient mice. Conclusions-Functional inhibition of the interaction between IL-1R1 and the necrosome complex improves neuron survival and promotes the recovery of neurological function in experimental ICH. Targeting IL-1R1/RIP1/RIP3 assembly could be a promising therapeutic strategy for patients with ICH. Visual Overview-An online visual overview is available for this article.
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hematomas, which demonstrates that danger-associated molecular patterns should not be ignored after hemorrhages. Some studies have proven that hemin potentiates microglia activation and aggravates inflammatory injury to neurons in a Toll Like Receptor 4-Myeloid differentiation primary response 88-dependent pathway after ICH. [8] [9] [10] Abundant evidence supports that inflammatory cytokines, necrosis tissue factors, or cellular metabolites can trigger overwhelming inflammation and result in severe secondary insults after ICH. 10, 11 Microglia-mediated brain inflammation has emerged as an important determinant targeted for ICH. However, the mechanism of hemin-induced neuron death directly is still unclear.
Cell death is a hall mark of secondary brain injury in ICH. There are different types of regulated cell death have been distinguished in recent researches, namely, apoptosis and necroptosis. 12 A growing number of studies have implicated apoptosis, ferroptosis, and necroptosis in human ICH subjects, as well as in rodent collagenase and autologous blood ICH models. 6, [13] [14] [15] [16] [17] Excitatory amino acids, inflammatory cytokines, and products released by hematomas were correlated with neuron apoptosis after ICH. 15, 16, 18, 19 As a kind of programmed cell death, necroptosis is morphologically shared with necrosis, with characterized by organelle swelling, loss of cellular contents, and cell membrane rupture. 20 As a result of changing plasma membrane integrity, the intracellular components are released into the extracellular environment from dead cells and triggers inflammatory response. 21 This process is different than apoptosis, where apoptotic cells maintain membrane integrity and thus avoid the subsequent inflammatory response in physiological and pathological processes.
Recently, researches have demonstrated that hemin could induce neuron cell death directly via ferroptosis and necroptosis mechanisms. 19, 22, 23 Ferrostatin-1, a specific inhibitor of ferroptosis, has been shown to attenuate iron deposition induced by hemoglobin and prevent neuron death via inhibiting cyclooxygenase-2 production. 23 The role of ferroptosis in hemin-induced neuron death has been well characterized.
Typically, necroptosis is mediated by RIP (receptor interacting protein) 1/RIP3 and a substrate of RIP3-MLKL (mixed lineage kinase domain-like protein), which can form a necrosis signaling complex called the necrosome. 24 Much of knowledge about necroptosis has come from TNF-α (tumor necrosis factor-α)-induced necroptosis. However, whether hemin is able to induce necroptosis and share a similar pathway with TNF-α remain unknown. The goal of the present study was to further understand the regulatory mechanism underlying hemin-induced neuronal necroptosis after ICH and provide a reference directing clinical treatment for this disease.
Materials and Methods
All data and description of methods are available in the article or in the online-only Data Supplement.
Chemicals and Reagents
Hemin (no. H9039) was obtained from Sigma. Interleukin-1 receptor antagonist (IL-1RA; no. 10123) purchased from Sino Biological. NEC-1, GSK872, and necrosulfonamide were obtained from MCE. Triton X-100 (no. HFH10) and Prestained Protein Ladder (no. 26616) were purchased from Thermo Fisher Scientific. Cytotoxicity lactate dehydrogenase Assay Kit (G1780) purchased from PROMEGA. Mouse TNF-α (no. MTA00B), mouse IL-6 (no. M6000B), mouse IL-1β (no. MLB00C), and human IL-1β (no. DLB50) ELISA kits were obtained from R&D. Antibodies were listed in the online-only Data Supplement.
Patients
The diagnosis and clinical data of patients with ICH injury were described in the online-only Data Supplement. All brain samples and cerebrospinal fluid (CSF) were obtained written informed consent from their families for this study.
Animals
A detailed description about mice-keeping and experimental processes was listed in the online-only Data Supplement.
ICH Model
A modified hemin-induced ICH model was performed as described previously. 8, 10 The detail processes were described in the online-only Data Supplement.
Primary Cultures of Hippocampal Neurons
Primary neurons were harvested from the hippocampus of 18-dayold mice fetuses according to the modified published protocol. 25 The detail processes were described in the online-only Data Supplement.
Lactate Dehydrogenase Assays
Cytotoxicity Assay Kit (Cat no. G1780, Promega) was used to measure the hemin toxicity to cultured neurons. The detail processes were described in the online-only Data Supplement.
Immunoprecipitation and Immunoblot
The immunoprecipitation and immunoblot were performed as previously reported. 9 The detail processes were described in the onlineonly Data Supplement.
Enzyme-Linked Immunosorbent Assay
Proinflammatory cytokines TNF-α, IL-6, and IL-1β were used via ELISA to assess the proinflammatory secretions in CSF of patients, supernatants of cultured neurons, and mice brain tissues (R&D).
Histology
For human surgical debridement brain tissues, serial 5-μm thick Paraffin-embedded sections were obtained with a microtome for histological studies. Hematoxylin and eosin staining was used to visualize the brain lesions of patients.
Immunohistochemical Staining
Immunohistochemical staining was conducted according to standard procedures. The detail processes were described in the online-only Data Supplement.
Immunofluorescent Staining
The immunofluorescent staining of brain samples and cultured neurons were performed as previously described. 9, 26 The detail processes were described in the online-only Data Supplement.
Propidium Iodide Staining
Propidium iodide staining analyses were used to quantify cell death according to the manufacturer's instructions (KeyGen, Nanjing, China). The percentage of cell death was analyzed using IPP software.
Neurological Deficit Scores
The neurological deficit tests were performed after treatment, including forelimb postural flexing test, body torsion, side thrust, circling or sidewalk, foot fault test, and climbing. Detailed procedures were performed as previously described. 8, 27, 28 Scoring was performed by the observers who were blind to the animals.
Measurement of Brain Water Content
The detail processes to measure brain water content were described in the online-only Data Supplement.
All human and animal studies were approved by respective Human Ethic Committee and Animal Management Committee of the Third Military Medical University.
Statistical Analysis
The detail description for statistical analysis was presented in the online-only Data Supplement.
Results

ICH Induces Neuronal Necroptosis in Human Brains
We began by studying pathological reactions of hematomas in patients with ICH. Magnetic resonance imaging showed the deposition of hematomas in basal ganglia region and a significant midline shift. Brain edema formation was observed when compared with contralateral areas of the brain in patients ( Figure 1A ). Hemachrome deposits, liquefactive necrosis, and inflammatory cell infiltration were all observed around the hematomas ( Figure 1B ).
The neurotoxic hemin is decomposed and catalyzed by heme oxygenase (HO) enzymes during ICH. HO enzymes, including the inducible HO (HO-1) and constitutively active HO (HO-2 and HO-3), can catabolize hemin to neurotoxic metabolic molecules. 29 HO-1 is always associated with the presence of hemin leading us to take HO-1 as a marker to explore the hemin distribution in hematomas. Immunostaining showed that HO-1 expression was mainly increased in neurons because it is always colocalized with neuronal nuclei-positive cells (neurons). Fewer HO-1-positive neurons were detected in the near adjacent hematomas areas ( Figure 1C ). In addition, highly positive terminal deoxynucleotidyl transferase mediated dUTP nick end labeling signals were detected in the neurons around hematomas ( Figure  I in the online-only Data Supplement). These results indicated that HO-1 was expressed in the injured neurons specifically, and hemin may induce neuron injury directly after ICH.
We next studied the necrosome expression of hematomas in patients via immunofluorescent staining. The levels of expression of RIP1, RIP3, and MLKL were significantly increased and mainly expressed in neurons ( Figure 1D ; Figure  II in the online-only Data Supplement), indicating that the RIP1-RIP3 complex was involved in the neuronal necroptosis associated with ICH.
Hemin Induced Neuronal Necroptosis via Necrosome Activation
To prove whether necroptosis could be induced by hemin, we intracranially microinject hemin to mice brain, which allowed 
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us exclude the possible confounding factors in the condition of ICH. We then investigated the expression of HO-1 in mice model. The immunohistochemical staining revealed that HO-1 was obviously expressed within hippocampus or cortex neurons of ipsilateral brain sections ( Figure III in the online-only Data Supplement) while it was not visible in the contralateral hemisphere (data not shown). Likewise, immunoblot results also confirmed that the protein levels of HO-1 and necrosome were significantly higher in the mice subjected to hemin than in the control groups (Figure 2A) . To define the role of hemin in triggering inflammatory injury after ICH, we then tested inflammatory cytokine secretion and brain swelling formation from 1 to 5 days and found that the levels of inflammatory cytokines TNF-α, IL-6, and IL-1β were significantly higher than the saline-treated groups onset of 1 day of hemin treatment and reached the peak at day 3 (3d; Figure 2B ). In addition, both the brain water content and neurological deficit scores were dramatically increased at 3d after hemin treatment ( Figure 2C and 2D). These results suggested that necroptosis and inflammatory injury both contributed to hemin-induced neuron death in ICH.
Hemin-Induced Neuronal Necroptosis Involves IL-1β Receptor IL-1R1
We next sought to investigate the cytotoxic effect of hemin on primary neurons. The concentration of lactate dehydrogenase was increased in a dose-dependent manner when treated with hemin. Briefly, 40 μmol/L of hemin caused a marked increase in cell death, but massive cell death was observed at concentrations of 80 μmol/L ( Figure 3A1 ). Therefore, we decided to use 40 μmol/L of hemin for next study, a maximal 4-fold increase in neuron death in response to 40 μmol/L hemin for 6 hours ( Figure 3A2 ). To determine whether hemin could affect necrosome activation, we then tested necrosome expression by immunoblot. Results showed that protein levels of RIP1, RIP3, and MLKL were significantly increased after hemin insult ( Figure 3B ). Caspase3-mediated cell apoptosis is another key event involved in neuron death in ICH. 11, 15, 16, 30 To evaluate whether apoptosis was involved hemin-induced neuron death, we examined the expression of caspase 3. Immunohistochemical staining of hematoma tissues from ICH patients showed that increased caspase 3 was detected in neurons ( Figure I in the online-only Data Supplement); however, we also found that the expression of caspase 3 was not affected in primary neurons after hemin administration ( Figure IV in the online-only Data Supplement). These findings indicated that hemin could trigger neuron death via a necroptotic pathway, and caspase 3-dependent apoptosis might not be involved in this process.
Generally, proinflammatory cytokines play a key role in inflammatory secondary injury after ICH. As one of the major proinflammatory cytokines, IL-1β has gradually become a significant source of interest. Strong evidence has suggested that IL-1RA could alleviate the neuron damage in experimental stroke models, 31, 32 which led us to explore whether IL-1β and IL-1 receptors were involved in neuronal necroptosis after ICH. We then measured the secretion of IL-1β in CSF from patients experiencing ICH. Normally, concentration of IL-1β in CSF is at low level. However, very high concentrations of IL-1β were noticed in the CSF of patients with ICH( Figure 3C1 ). Consistent with this result, treatment with hemin induced higher secretion of IL-1β in primary neurons ( Figure 3C2 ). Increased IL-1β often accompanies elevated levels of the IL-1 receptor. Many detrimental effects of IL-1β have been associated with overactivation of the IL-1 receptor, and we then analyzed the expression of IL-1R1 in clinical samples. Immunostaining showed the enhanced expression of IL-1R1 in neurons around the hematomas ( Figure 3D1 ). We then studied whether IL-1R1 participated in hemin-induced necroptosis both in vivo and in vitro. The levels of IL-1R1 in the brain issues were significantly higher in the mice subjected to hemin than in the mice of control groups ( Figure V in the onlineonly Data Supplement; Figure 3D2 ). Consistently, immunoblot from cultured neurons showed that IL-1R1 expressions were also increased dramatically after hemin treatment ( Figure 3B ). These findings suggest that IL-1R1 signaling pathway is involved in hemin-induced neuronal necroptosis.
IL-1RA Prevents Hemin-Induced Neuronal Necroptosis Though Inhibition of Necrosome Activation
Having demonstrated that IL-1R1 participated in hemin-induced necroptosis both in vivo and in vitro, we speculated that IL-1RA might be able to interfere with hemin-induced neuronal necroptosis. We then conducted pre-treatment with IL-1RA for 1 hour before a hemin insult to primary neurons, and lactate dehydrogenase analysis was performed to determine its cytotoxic effects. 
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Results showed that IL-1RA significantly reduced the number of cell deaths ( Figure 4A ). Recent researches have demonstrated that phosphorylated MLKL can form oligomers and translocate to the cell membrane to disrupt membrane integrity, which can be reflected by PI staining. 33, 34 Still, we found that IL-1RA could promote neuron survival by maintaining cell membrane integrity ( Figure 4D ). Taken together, our results suggest that IL-1RA can prevent hemin-induced necroptosis via inhibition of RIP1, RIP3, and the necroptosis-affecter MLKL.
Hemin Triggers Neuronal Necroptosis Though Promotion of IL-1R1 and RIP Complex Formation
As shown above, enhancement of the IL-1 receptor can cause neuronal necroptosis while many studies have suggested that RIPs might be the core step for necroptosis activation. According to the above results, we could hypothesize logically that activated IL-1 receptor may induce RIP activation and result in neuronal necroptosis induced by hemin. We performed co-immunoprecipitation to define the physical basis and potential pathway between IL-1R1 and necroptosis-associated proteins. From the cultured neurons, we found that hemin promoted the binding of IL-1R1 with RIP1-RIP3 as depicted in Figure 5A . Immunostaining from clinical samples further confirmed our finding that IL-1R1 could form a complex with RIP1-RIP3 after ICH ( Figure 5B) . Moreover, IL-1R1 antagonist abolished the interaction between IL-1R1 and necrosome after hemin treatment ( Figure 5A ). These results indicated that hemin may trigger neuronal necroptosis by inducing IL-1R1 and RIP complex formation.
Genetic Deletion of IL-1R1 Mitigates Hemin-Induced Neuronal Necroptosis and Inflammatory Response
Once we demonstrated the inhibitory effect of IL-1RA on necroptosis activation in vitro, we decided to explore the protective effect of IL-1RA in vivo. We injected hemin-treated mice with IL-1RA. Results showed that administration of hemin significantly induced the expression of RIP1, RIP3, and MLKL, with expression levels peaking at 1 day after the initial hemin treatment and then gradually decreasing. Postadministration of IL-1RA resulted in a marked decrease in necrosome expression levels at day 1; however, the expression of RIP1 and RIP3 increased at 3 days followed by a gradual decrease. The necroptosis executor MLKL could be inhibited by IL-1RA at all times tested ( Figure IX 
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revealed that protein levels of both HO-1 and the necrosome in IL-1R1 −/− were significantly lower than in wild-type mice after 1 day of hemin injection ( Figure 6B ). Consistent with immunoblot results, the immunofluorescent staining analysis also revealed that the levels of RIP1 and RIP3 were consistently inhibited in the brain of IL-1R1 −/− mice ( Figure 6C ). It is established that RIP1 kinase activity is implicated in the inflammatory response and required to execute necroptosis. 35 We found phospho-RIP1(S166) was also significantly lower in IL-1R1 Furthermore, the relative levels of proinflammatory cytokines TNF-α, IL-6, and IL-1β were significantly lower in IL-1R1 −/− mice than in hemin-treated wild-type mice ( Figure 6D ). Together with the findings, these results suggested that hemin could trigger IL-1R1-mediated neuronal necroptosis directly and that IL-1R1 is a potential target for ICH disease.
Discussion
Neuron death is a hallmark of ICH. However, the signal pathway by which the cellular events contribute to neuron death is not fully understood till now. Here, we explored the mechanism of hemin-induced neuronal necroptosis after ICH. Because ruptured intracranial artery is the common reasons of ICH and hippocampal neurons are most vulnerable to secondary damage, so we use cultured hippocampus neurons for this study. Our results demonstrated that the RIP1-RIP3 complex was activated and participated in neuronal necroptosis. In addition, we found that necrosome complex formation with IL-1R1 is a prerequisite for the activation of RIP1, RIP3, and MLKL in response to hemin stimulation. Disrupting the interaction between IL-1R1 and the necrosome by applying inhibitors or using a genetic model approach could inhibit necrosome activation and protect neurons from hemin-induced cell death. Taken together, our results demonstrated a novel role of IL-1R1 in controlling hemin neurotoxicity and neurological function disorders after ICH.
Both hemoglobin and hemin share the feature of oxidative stress and are toxic to various kinds of cell types, including astrocytes and neurons, after ICH. 36, 37 In the hemorrhagic stroke, the concentrations of hemin can reach up to 10 mmol/L for maximum in hematomas, 37, 38 which introduced us to a possible a therapeutic target to protect neurons from death in ICH. Our results demonstrated that HO-1 and necroptosisassociated proteins RIP1, RIP3, and MLKL were significantly expressed mainly in neurons from clinical samples, reflecting the existence of neuronal necroptosis in this disease. The enhanced expressions of necroptosis molecules were also observed in the animal model, which further confirmed our findings.
Previous studies also demonstrated that hemin could induce inflammatory injury accompanied by cytokines TNF-α and IL-6 in a Toll Like Receptor 4-dependent manner. 8, 9 Besides TNF-α and IL-6-mediated central nervous system injury, IL-1 is also involved in inflammatory injury and neuron death in acute central nervous system disease. 39 Our experiments both in vivo and in vitro revealed that hemin also triggered IL-1β release in both patient CSF and cultured neurons. IL-1 and its receptor IL-1R1 are widely believed to be involved in coordinating inflammatory response during pathogen invasion. 40 We were able to demonstrate an immediate and enhanced expression of IL-1R1 in neurons both in vivo and in vitro, indicating that IL-1 signaling and IL-1R1 were involved in activation of the innate immune response induced by hemin.
The molecular mechanisms of ICH-induced cell death have been a major focus of research efforts, with many studies emphasizing the roles of caspase-regulated apoptosis. 11, 15, 18 It is important to consider the safety of putting caspase inhibitors as the therapy target in clinical trials as caspase activity inhibitors may still cause cells in a necroptotic fashion although Nec-1 (an inhibitor of RIP1) can be remarkable attenuate neurological dysfunction, brain edema formation. 13, 19 However, Nec-1 could not applied in clinical treatment as Nec-1 also inhibit indoleamine-2,3-dioxygenase, which may interfere innate and adaptive immune response. 41 Therefore, it is urgent to find new targets and develop new strategies to alleviate the neuron death after ICH or in other diseases. Clinical trials have shown that intravenous infused with IL-1RA can effectively across the blood brain barrier without any side effects on the patients with subarachnoid hemorrhage. 42 In mouse models of focal cerebral ischemia or excitotoxic damage, IL-1RA shows great neuroprotective effects and results in diminished cell death. 39, 43 Our study further demonstrated the requirement of IL-1R1 for necrosome activation, providing new evidence of the controlling activities of RIPs during the process of neuronal necroptosis. In addition, we found a significant interaction between IL-1R1 and RIP1/RIP3 in neurons from patients with ICH and cultured neurons for the first time, confirming that the interaction between IL-1R1 and RIP1/RIP3 may be crucial to trigger neuronal necroptosis after ICH.
Taken together, our data suggest that hemin triggers neuronal necroptosis in ICH via the induction of IL-1R1-RIP complex formation. These findings elucidated the clinical use of IL-1R1 inhibitor for neuroprotection. When ICH occurs, functional inhibition of IL-1R1 is a potentially beneficial approach for attenuating neuron death as genetic deletion of IL-1R1 can both limit hemin-induced necroptosis and the inflammatory response.
In this study, we just focused at how hemin can induce necroptosis after ICH. In fact, ferroptosis and other cell death would take place. Meanwhile, we used hippocampal neuron as cell model instead of cortex or ganglion neurons, which might limit the potential effect in clinical application. Further efforts are required to elucidate the neuron death mechanism induced by hemin and other dangerous factors after ICH.
